Alfredo Nicosia | PhD
Alfredo was previously a co-founder and Chief Scientific Officer of Okairos, leading preclinical and clinical development of several vaccines and monoclonal antibodies against infectious diseases [...]
Alfredo was previously a co-founder and Chief Scientific Officer of Okairos, leading preclinical and clinical development of several vaccines and monoclonal antibodies against infectious diseases [...]
Antonella was a co-founder of Okairos and served as the company’s Director of Immunology. Her experience includes the positions of Researcher and Group Leader at IRBM, where she focused her [...]
Stefano was a co-founder of Okairos and served as the company’s Senior Director for Vector Development. Today he also leads GMP manufacturing at Keires’ subsidiary in Italy. Stefano’s experience [...]
Cinzia is Nouscom co-founder and Senior Director of Regulatory Affairs since year 2015. Her previous experience included 17 years at the Merck laboratory in Rome (IRBM), mainly as a group leader [...]
Nouscom is a private oncology company developing next generation immunotherapies, founded in 2015 by an experienced management team that has worked together for many years in previous successful enterprises. Nouscom’s proprietary technology platform harnesses the full power of the immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators.